Castaneda, M.; den Hollander, P.; Werden, S.; Ramirez-Peña, E.; Vasaikar, S.V.; Kuburich, N.A.; Gould, C.; Soundararajan, R.; Mani, S.A.
β-Catenin Drives the FOXC2-Mediated Epithelial–Mesenchymal Transition and Acquisition of Stem Cell Properties. Cancers 2025, 17, 1114.
https://doi.org/10.3390/cancers17071114
AMA Style
Castaneda M, den Hollander P, Werden S, Ramirez-Peña E, Vasaikar SV, Kuburich NA, Gould C, Soundararajan R, Mani SA.
β-Catenin Drives the FOXC2-Mediated Epithelial–Mesenchymal Transition and Acquisition of Stem Cell Properties. Cancers. 2025; 17(7):1114.
https://doi.org/10.3390/cancers17071114
Chicago/Turabian Style
Castaneda, Maria, Petra den Hollander, Steve Werden, Esmeralda Ramirez-Peña, Suhas V. Vasaikar, Nick A. Kuburich, Claire Gould, Rama Soundararajan, and Sendurai A. Mani.
2025. "β-Catenin Drives the FOXC2-Mediated Epithelial–Mesenchymal Transition and Acquisition of Stem Cell Properties" Cancers 17, no. 7: 1114.
https://doi.org/10.3390/cancers17071114
APA Style
Castaneda, M., den Hollander, P., Werden, S., Ramirez-Peña, E., Vasaikar, S. V., Kuburich, N. A., Gould, C., Soundararajan, R., & Mani, S. A.
(2025). β-Catenin Drives the FOXC2-Mediated Epithelial–Mesenchymal Transition and Acquisition of Stem Cell Properties. Cancers, 17(7), 1114.
https://doi.org/10.3390/cancers17071114